BioDelivery-Collegium Collaborate for Onsolis in U.S.

BioDelivery Sciences International, Inc.BDSI and Collegium Pharmaceutical, Inc. COLL have entered into a licensing deal under which Collegium will gain exclusive rights for the development and marketing of Onsolis in the U.S. Onsolis is approved for the management of